Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport

Raymond Quigley1, Michel Baum1,2, Komandla Malla Reddy3, James C. Griener1, and J. R. Falck3

Departments of 1 Pediatrics, 2 Internal Medicine, and 3 Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235-9063


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The kidney has the highest abundance of cytochrome P-450 of all extrahepatic organs. Within the kidney, the highest concentration of cytochrome P-450 is found in the proximal tubule. Whether 20- or 19(S)-hydroxyeicosatetraenoic acid (HETE), the major P-450 metabolites of arachidonic acid in the proximal tubule, affect transport in this segment has not been previously investigated. We examined the direct effects of 20- and 19(S)-HETE on volume absorption (Jv) in the rabbit proximal straight tubule (PST). Production of 20-HETE by rabbit PST was demonstrated by incubating microdissected tubules with [3H]arachidonic acid and separating the lipid extract by HPLC. There was significant conversion of [3H]arachidonic acid to 20-HETE in control tubules that was inhibited by 10-5 M N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS). Addition of exogenous 20-HETE had no effect on PST volume transport. However, inhibition of endogenous production of 20-HETE using DDMS stimulated transport. In the presence of DDMS, 20-HETE inhibited PST Jv. 19(S)-HETE in the bathing solution stimulated PST Jv alone and in the presence of DDMS. Thus omega - and omega -1-hydroxylase products of arachidonic acid have direct effects on PST transport. Endogenous production of 20-HETE may play a role in tonic suppression of transport and may therefore be an endogenous regulator of transport in the proximal tubule.

in vitro microperfusion; cytochrome P-450; omega -hydroxylase; hypertension; sodium-potassium-adenosinetriphosphatase; hydroxyeicosatetraenoic acids


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

THE MAMMALIAN RENAL CORTEX is an abundant source of cytochrome P-450 isozymes (21, 32). Within the kidney, the highest concentration of cytochrome P-450 is found in the proximal tubule (12). The isozymes present in the rat proximal tubule have recently been shown to be in the CYP4A class and metabolize arachidonic acid predominately by the omega -hydroxylase pathway (17). Microsomes from rabbit renal cortex have also been shown to metabolize arachidonic acid by the omega -hydroxylase pathway to 20- and 19(S)-hydroxyeicosatetraenoic (HETE) acids (23).

Metabolites of the renal cytochrome P-450 omega -hydroxylase system have multiple effects on renal function. Infusion of 20-HETE into rat renal arteries resulted in natriuresis without affecting glomerular filtration rate or systemic blood pressure (34). Inhibition of endogenous omega -hydroxylase activity by infusion of 17-octadecynoic acid into rat renal arteries also caused an increase in urine flow rate and sodium excretion (38). These results are difficult to interpret, because these compounds are known to alter renal hemodynamics and affect transport in multiple nephron segments (1, 3, 13, 14, 16, 22, 27, 31). 20-HETE constricts canine renal arcuate arteries (22) and rat renal arterioles (16) and increases renal vascular resistance (1). The vascular effects of 20-HETE also play a role in autoregulation and tubuloglomerular feedback (36, 37). 20-HETE has been shown to modulate thick ascending limb sodium chloride transport (3, 13, 14, 31). Cells from the thick ascending limb produce 20-HETE in culture, and production is stimulated by arginine vasopressin and calcitonin (13, 31). 20-HETE inhibits transport in the thick ascending limb by blocking the Na-K-2Cl cotransporter (3, 14). This inhibitory effect of 20-HETE on transport may be part of the signal transduction mechanism for the inhibition of transport by pharmacological doses of angiotensin II in this segment (4).

The proximal tubule is a major site of renal cytochrome P-450 (12, 17, 22). It has been estimated that the majority of 20-HETE produced by the kidney comes from the proximal tubule (20). The effects of 20-HETE on proximal tubule transport remain unknown. The purpose of the present study was to directly examine the effect of 20- and 19(S)-HETE on volume transport in the in vitro microperfused rabbit proximal straight tubule (PST).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Production of 20-HETE. The production of 20-HETE from rabbit PST was measured using a modification of the method developed by Ito and Roman (18). Briefly, PST from rabbit kidneys were dissected as described below and transferred to a test tube in Hanks' solution. The tubules were permeabilized with three freeze-thaw cycles using liquid nitrogen to snap freeze the tissue, followed by thawing in warm water. The tubules were then centrifuged at 4°C at 2,000 rpm for 5 min. The supernatant was aspirated, and the cells were resuspended in 1 ml of a buffer containing (in mM) 100 potassium phosphate (pH 7.4), 10 MgCl2, and 1 EDTA. [3H]arachidonic acid (4 µCi/ml; New England Nuclear, Boston, MA), 1 mM NADPH, 10 mM isocitrate, and 0.4 U/ml isocitrate dehydrogenase (as an NADPH generating system) were then added to each tube. The tubes were then incubated at 37°C for 60 min with 100% O2 blown over the tops. Three tubes were control with vehicle added, and three tubes were treated with 10-5 M N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS). One tube contained the solutions without tubules to assess the rate of nonenzymatic conversion to 20-HETE. The reaction was terminated by adding 250 µl of 1 M formic acid. The lipids were then extracted by adding 2 ml of chloroform, vortexing, centrifuging at 2,000 rpm for 5 min, and then drying under nitrogen. The samples were then resuspended in 20 µl of ethanol and separated by HPLC using a C18 column (150 × 2.1 mm, 3 µm, ODS, Hypersil; ThermoQuest, San Jose, CA). The mobile phase was an acetonitrile:water:acetic acid (62.5:37.5:0.5) gradient to 100% acetonitrile in 20 min. Retention times for 20-HETE and arachidonic acid were determined by running standards under the same conditions. The fraction that came off at 7 min corresponded to 20-HETE, and the fraction at 19 min corresponded to arachidonic acid. Using this system, we found it was not possible to separate 19- from 20-HETE. The aqueous phase was saved to determine the protein concentration by bicinchoninic acid assay (BCA; Pierce Chemical, Rockford, IL).

Results were calculated by counting the 7- and 19-min fractions in a liquid scintillation counter. The counts were totaled, and the 20-HETE fraction was expressed as a fraction of the total, then factored for protein concentration. Results are expressed as the mean and standard error. Comparisons were made using unpaired t-test and significance was taken to be P < 0.05.

In vitro microperfusion. Superficial PST (S2 segment) from New Zealand White rabbits were perfused in vitro as previously described (11, 26). Briefly, PST were dissected in cooled (4°C) modified Hanks' solution containing (in mM) 137 NaCl, 5 KCl, 0.8 MgSO4, 0.33 Na2HPO4, 0.44 KH2PO4, 1 MgCl2, 10 Tris · HCl, 0.25 CaCl2, 2 glutamine, and 2 L-lactate. This solution was bubbled with 100% O2 and had a pH of 7.4. Tubules were then transferred to a 1.2-ml thermostatically controlled (37-38°C) bathing chamber and perfused with concentric glass pipettes. The perfusion solution simulated an ultrafiltrate of plasma and contained (in mM) 115 NaCl, 25 NaHCO3, 2.3 Na2HPO4, 10 sodium acetate, 1.8 CaCl2, 1 MgSO4, 5 KCl, 8.3 glucose, and 5 alanine. The bathing solution was similar, but contained 6 g/dl of albumin. All solutions were bubbled with 95% O2 and 5% CO2 at 37°C and had a pH of 7.4. The osmolalities of the perfusion and bathing solutions were adjusted to 295 mosmol/kgH2O by the addition of water or NaCl. The bathing solution was exchanged at a rate of 0.5 ml/min to keep the osmolality and pH constant.

The control period began after a 60-min incubation period. Volume absorption (Jv; in nl · min-1 · mm-1) was measured as the difference between the perfusion and collection rates and normalized per millimeter of tubule length. The collection rate was determined by timed collections using a constant-volume pipette. Exhaustively dialyzed [methoxy-3H]inulin (New England Nuclear) was added to the perfusate at a concentration of 50 µCi/ml so that the perfusion rate could be calculated. The tubule length (L) was measured using an eyepiece micrometer.

The transepithelial potential difference (PD, mV) was measured by using the perfusion pipette as the bridge into the tubular lumen. The recording and reference calomel half-cells were connected to the perfusion and bathing solutions via agarose bridges containing 3.6 M KCl/0.9 M KNO3. This arrangement avoids direct contact between the solution bathing the tubule and the KCl/KNO3 agarose bridge. The recording and reference calomel half-cells were then connected to the high- and low-impedance sides, respectively, of an electrometer (model 602; Keithley Instruments, Cleveland, OH).

After five control measurements of Jv and PD were made, the eicosanoid to be studied was added to the bathing solution. After 15 min of incubation, five measurements of Jv and PD were made in the experimental period. Measurements of Jv and PD in each period were averaged for that period.

Results are expressed as the means and standard error of all tubules in each series. Comparisons were made using paired t-test and significance was taken to be P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

20-HETE production. Rabbit proximal tubules were shown to metabolize arachidonic acid to 20-HETE. The control rate of conversion was 47.7 ± 3.4 (0.18 ± 0.02% · µg protein-1 · 60 min-1). DDMS significantly reduced this conversion rate to 17.7 ± 1.8% · tube-1 · 60 min-1 (0.05 ± 0.01% · µg protein-1 · 60 min-1; P < 0.01, n = 3). The nonenzymatic conversion of arachidonic acid to 20-HETE was minimal (9.5% · tube-1 · 60 min-1) and was approximately the same as the DDMS-treated tubules. Thus rabbit PST are capable of producing 20-HETE and this is inhibited by DDMS.

In vitro microperfusion. The first series of experiments was designed to determine whether 20-HETE had a direct effect on PST Jv. During the experimental period in these series, 20-HETE (10-6 M or 10-5 M) was added to the bathing solution. 20-HETE had no direct effect on Jv [control, 0.50 ± 0.10 vs. 10-6 M 20-HETE, 0.50 ± 0.12 nl · min-1 · mm-1; n = 4, P = not significant (NS); and control, 0.45 ± 0.12 vs. 10-5 M 20-HETE, 0.46 ± 0.14 nl · min-1 · mm-1; n = 6, P = NS]. There was also no change in the PD (control, -1.2 ± 0.3 vs. 10-6 M 20-HETE, -1.2 ± 0.2 mV; and control, -2.2 ± 0.9 vs. 10-5 M 20-HETE, -2.3 ± 0.8 mV; P = NS).

Since the major metabolite of arachidonic acid in rat proximal tubules is 20-HETE (24) and we had demonstrated that rabbit proximal tubules also produce 20-HETE, it is possible that the endogenous production rate is sufficiently high to mask the effect of any exogenously administered 20-HETE. To evaluate this possibility, endogenous production of 20-HETE was blocked using DDMS, an omega -hydroxylase inhibitor with little effect on epoxygenase activity (1). Figure 1 shows the effect of 10-6 M DDMS when added to the bath. This concentration stimulated Jv in the proximal tubule (control, 0.35 ± 0.04 vs. 10-6 M DDMS, 0.44 ± 0.05 nl · min-1 · mm-1; P < 0.05). There was no change in the PD (control, -2.0 ± 0.7 vs. 10-6 M DDMS, -2.0 ± 0.4 mV; P = NS). Thus inhibition of endogenous production of 20-HETE resulted in a 26% stimulation in proximal tubule transport.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   The effect of inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) production on proximal straight tubule (PST) transport. During the experimental period, 10-6 M N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) was added to the bath (n = 3). DDMS is a specific inhibitor of the omega -hydroxylase enzyme. There was a significant stimulation of transport. *P < 0.05 vs. control. Jv, volume absorption.

The next series of experiments examined the effect of addition of 20-HETE in the presence of DDMS. As seen in Fig. 2, when endogenous 20-HETE production is inhibited with 10-5 M DDMS, exogenous administration of 10-5 M 20-HETE has a direct effect to inhibit transport in the PST [control, 0.49 ± 0.05 vs. 10-5 M DDMS, 0.58 ± 0.06 nl · min-1 · mm-1 (P < 0.05) vs. 10-5 M DDMS and 10-5 M 20-HETE, 0.52 ± 0.05 nl · min-1 · mm-1 (P < 0.05)]. There was no effect of 20-HETE on the PD [control, -1.1 ± 0.3 vs. 10-5 M DDMS, -1.3 ± 0.3 mV (P = NS) vs. 10-5 M DDMS and 10-5 M 20-HETE, -1.4 ± 0.3 mV (P = NS)].


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of 20-HETE in the presence of omega -hydroxylase inhibition (n = 7). Addition of 10-5 M DDMS to the bath significantly stimulated Jv. In the presence of 10-5 M DDMS, 20-HETE (10-5 M) inhibited PST Jv. *P < 0.05 vs. DDMS (10-5 M).

The effect of 19(S)-HETE was examined in the last series of experiments. The addition of 10-6 M 19(S)-HETE was shown to stimulate proximal tubule transport (Fig. 3A) [control, 0.32 ± 0.05 vs. 19(S)-HETE 10-6 M, 0.42 ± 0.04 nl · min-1 · mm-1; P < 0.05]. There was no change in the PD [control, -1.6 ± 0.5 vs. 10-6 M 19(S)-HETE, -1.6 ± 0.3 mV; P = NS]. Because this stimulation could have occurred secondary to inhibition of 20-HETE production (2), the effects of 19(S)-HETE were examined in the presence of DDMS. As can be seen in Fig. 3B, 19(S)-HETE stimulated proximal tubule transport when endogenous 20-HETE production was inhibited [10-5 M DDMS, 0.30 ± 0.05 vs. 10-5 M DDMS and 10-5 M 19(S)-HETE, 0.38 ± 0.06 nl · min-1 · mm-1; P < 0.05]. Thus the effect to stimulate transport must be a direct effect and not due to any effect on 20-HETE production.



View larger version (1213K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of 19(S)-HETE on PST transport. The addition of 19(S)-HETE directly stimulated PST volume transport. A: 19(S)-HETE is added alone (10-6 M, n = 7). B: 19(S)-HETE (10-5 M, n = 6) is added in the presence of 10-5 M DDMS. Thus the effect of 19(S)-HETE on PST transport is not dependent on an interaction with 20-HETE. *P < 0.05 vs. control (A) or vs. 10-5 M DDMS (B).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The present study examined the direct effects of omega -hydroxylase products of arachidonic acid on proximal tubule volume transport. We demonstrated that rabbit PST are capable of converting arachidonic acid to 20-HETE. This conversion is inhibited by DDMS. Addition of exogenous 20-HETE, the major product of omega -hydroxylase, had no direct effect on PST volume transport. Inhibition of 20-HETE production with the omega -hydroxylase inhibitor, DDMS, stimulated volume transport in the PST. This implies that the high endogenous production of 20-HETE may play a role in suppressing transport rates. In the presence of DDMS, exogenous 20-HETE had a significant effect to inhibit transport. The omega -1 product of arachidonic acid, 19(S)-HETE, stimulated transport regardless of whether DDMS was present. This indicates that 19(S)-HETE directly stimulates transport without having to affect 20-HETE metabolism. Thus the omega -hydroxylase products of arachidonic acid play a role in the control of volume transport in the PST.

Although the effects of these compounds on proximal tubule transport have not been previously examined, their effects on Na-K-ATPase activity have been studied (15, 25, 27). 20-HETE inhibits Na-K-ATPase in this segment and is thought to play a role in the effect of parathyroid hormone and dopamine to inhibit transport in this segment (25, 27). 19(S)-HETE, the major omega -1 product of omega -hydroxylase, has been shown to stimulate rat renal Na-K-ATPase activity (15). Although Na-K-ATPase activity in the proximal tubule is a determinant of solute and volume transport, effects on the Na-K-ATPase do not always correlate with effects on Jv. Dopamine, for example, has been shown to inhibit proximal convoluted tubule Na-K-ATPase but has no direct effect on transport in this segment (5, 9, 10). Thus the relationship between regulating Na-K-ATPase activity and Jv rates is complex and indicates the importance of directly examining proximal tubule transport.

Changes in Jv rates in the present study were not associated with changes in PD. This is in contrast to previous studies in which increases in Jv rate correlated with increases in the PD (6) and decreases in transport correlated with decreases in the PD (8, 29). This suggests that the mechanism by which the Jv rates were increased may be due to changes in electroneutral transport and not due to direct changes in the Na-K-ATPase (7).

The proximal tubule reabsorbs between 60 and 70% of the glomerular ultrafiltrate (30). Thus small changes in the volume absorption rate in this nephron segment lead to large changes in overall fluid balance of the organism. Inhibiting omega -hydroxylase activity in this nephron segment led to an increase in transport by 16-28%, which could then cause volume overload and hypertension. This indicates that renal P-450 omega -hydroxylase may be involved in extracellular fluid volume and blood pressure regulation.

The role of the renal P-450 system in the development of hypertension has been complex. The Dahl salt-sensitive rat (SS) is a model of hypertension that has been extensively studied, and renal cytochrome P-450 abnormalities may be involved in the development of hypertension in this model (28). In vivo perfusion studies indicate that the SS rats reabsorb more sodium in the loop of Henle than the salt-resistant (SR) or Lewis rats, indicating that tubular transport is higher in these animals (33, 35). Addition of 20-HETE to the perfusate in these studies reduced the chloride transport rates (35). More recently, thick ascending limbs from SS animals were shown to have higher transport rates that were reduced with 20-HETE than SR animals (19). Thus 20-HETE is a key factor in regulating sodium and chloride transport and volume regulation.

The above in vivo and in vitro studies examined the role of 20-HETE on thick ascending limb of Henle transport (19, 33, 35). Since the highest concentration of renal P-450 is in the proximal tubule, the effect of 20-HETE production on transport in this segment was important to examine (12). The present study directly demonstrates that endogenous production of 20-HETE exerts an effect to inhibit transport in the PST. When the endogenous production was blocked, exogenous administration of 20-HETE inhibited transport. These findings are consistent with the above studies linking a low production rate of 20-HETE with the development of hypertension.

The present study demonstrated direct effects of 20- and 19(S)-HETE on proximal tubule transport. The addition of 20-HETE inhibited proximal tubule transport only when endogenous production was inhibited with DDMS. 19(S)-HETE was capable of stimulating volume transport in the absence and presence of DDMS. Thus the omega -hydroxylase products of arachidonic acid play a role in regulating proximal tubule transport.


    ACKNOWLEDGEMENTS

We are grateful for the technical assistance provided by Amber Lisec and the secretarial assistance of Janell McQuinn.


    FOOTNOTES

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-02232 (R. Quigley), DK-41612 (M. Baum), and DK-38226 (R. Quigley and J. R. Falck), and by the Robert A. Welch Foundation (J. R. Falck).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: R. Quigley, Dept. of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9063 (E-mail: RQUIGL{at}medmet.swmed.edu).

Received 28 April 1999; accepted in final form 19 January 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Alonso-Galicia, M, Drummond HA, Reddy KK, Falck JR, and Roman RJ. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 29: 320-325, 1997[Abstract/Free Full Text].

2.   Alonso-Galicia, M, Falck JR, Harder DR, and Roman RJ. Structural determinants of the renal vascular response to 20-hydroxyeicosatetraenoic acid (20-HETE). FASEB J 11: A244, 1997.

3.   Amlal, H, Legoff C, Vernimmen C, Paillard M, and Bichara M. Na+-K+(NH+4)-2Cl- cotransport in medullary thick ascending limb: control by PKA, PKC, and 20-HETE. Am J Physiol Cell Physiol 271: C455-C463, 1996[Abstract/Free Full Text].

4.   Amlal, H, Legoff C, Vernimmen C, Soleimani M, Paillard M, and Bichara M. ANG II controls Na+-K+(NH+4)-2Cl- cotransport via 20-HETE and PKC in medullary thick ascending limb. Am J Physiol Cell Physiol 274: C1047-C1056, 1998[Abstract/Free Full Text].

5.   Aperia, A, Bertorello A, and Seri I. Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted segments. Am J Physiol Renal Fluid Electrolyte Physiol 252: F39-F45, 1987[Abstract/Free Full Text].

6.   Baum, M. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 79: 1104-1109, 1987[ISI][Medline].

7.   Baum, M, and Berry CA. Evidence for neutral transcellular NaCl transport and neutral basolateral chloride exit in the rabbit convoluted tubule. J Clin Invest 74: 205-211, 1984[ISI][Medline].

8.   Baum, M, and Hays SR. Phorbol myristate acetate and dioctanoylglycerol inhibit transport in rabbit proximal convoluted tubule. Am J Physiol Renal Fluid Electrolyte Physiol 254: F9-F14, 1988[Abstract/Free Full Text].

9.   Bello-Reuss, E, Higashi Y, and Kaneda Y. Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 242: F634-F640, 1982[ISI][Medline].

10.   Bertorello, A, and Aperia A. Inhibition of proximal tubule Na+-K+-ATPase activity requires simultaneous activation of DA1 and DA2 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 259: F924-F928, 1990[Abstract/Free Full Text].

11.   Burg, MB, Grantham J, Abramow M, and Orloff J. Preparation and study of fragments of single rabbit nephrons. Am J Physiol 210: 1293-1298, 1966[ISI][Medline].

12.   Endou, H. Cytochrome P-450 monooxygenase system in the rabbit kidney: its intranephron localization and its induction. Jpn J Pharmacol 33: 423-433, 1983[ISI][Medline].

13.   Escalante, B, Erlij D, Falck JR, and McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991[ISI][Medline].

14.   Escalante, B, Erlij D, Falck JR, and McGiff JC. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol Cell Physiol 266: C1775-C1782, 1994[Abstract/Free Full Text].

15.   Escalante, B, Falck JR, Yadagiri P, Sun L, and Laniado-Schwartzman M. 19(S)-Hydroxyeicosatetraenoic acid is a potent stimulator of renal Na+-K+-ATPase. Biochem Biophys Res Commun 152: 1269-1274, 1988[ISI][Medline].

16.   Imig, JD, Zou AP, Stec DE, Harder DR, Falck JR, and Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol Regulatory Integrative Comp Physiol 270: R217-R227, 1996[Abstract/Free Full Text].

17.   Ito, O, Alonso-Galicia M, Hopp KA, and Roman RJ. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol Renal Physiol 274: F395-F404, 1998[Abstract/Free Full Text].

18.   Ito, O, and Roman RJ. Regulation of P-450 4A activity in the glomerulus of the rat. Am J Physiol Regulatory Integrative Comp Physiol 276: R1749-R1757, 1999[Abstract/Free Full Text].

19.   Ito, O, and Roman RJ. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Hypertension 33: 419-423, 1999[Abstract/Free Full Text].

20.   Kroetz, DL, Huse LM, Thuresson A, and Grillo MP. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol 52: 362-372, 1997[Abstract/Free Full Text].

21.   Laniado-Schwartzman, M, and Abraham NG. The renal cytochrome P-450 arachidonic acid system. Pediatr Nephrol 6: 490-498, 1992[ISI][Medline].

22.   Ma, YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136, 1993[Abstract].

23.   Morrison, AR, and Pascoe N. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex. Proc Natl Acad Sci USA 78: 7375-7378, 1981[Abstract].

24.   Omata, K, Abraham NG, and Schwartzman ML. Renal cytochrome P-450 arachidonic acid metabolism: localization and hormonal regulation in SHR. Am J Physiol Renal Fluid Electrolyte Physiol 262: F591-F599, 1992[Abstract/Free Full Text].

25.   Ominato, M, Satoh T, and Katz AI. Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J Membr Biol 152: 235-243, 1996[ISI][Medline].

26.   Quigley, R, and Baum M. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88: 368-374, 1991[ISI][Medline].

27.   Ribeiro, CMP, Dubay GR, Falck JR, and Mandel LJ. Parathyroid hormone inhibits Na+-K+-ATPase through a cytochrome P-450 pathway. Am J Physiol Renal Fluid Electrolyte Physiol 266: F497-F505, 1994[Abstract/Free Full Text].

28.   Roman, RJ, Alonso-Galicia M, and Wilson TW. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens 10: 63S-67S, 1997[Medline].

29.   Salmon, RF, and Baum M. Intracellular cystine loading inhibits transport in the rabbit proximal convoluted tubule. J Clin Invest 85: 340-344, 1990[ISI][Medline].

30.   Sands, JM, Kokko JP, and Jacobson HR. Intrarenal heterogeneity: vascular and tubular. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW.. New York: Raven, 1992, p. 1087-1155.

31.   Schwartzman, M, Ferreri NR, Carroll MA, Songu-Mize E, and McGiff JC. Renal cytochrome P450-related arachidonate metabolite inhibits (Na++K+)ATPase. Nature 314: 620-622, 1985[ISI][Medline].

32.   Schwartzman, ML, and McGiff JC. Renal cytochrome P450. J Lipid Mediat Cell Signal 12: 229-242, 1995[ISI][Medline].

33.   Stec, DE, Mattson DL, and Roman RJ. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension 29: 315-319, 1997[Abstract/Free Full Text].

34.   Takahashi, K, Capdevila J, Karara A, Falck JR, Jacobson HR, and Badr KF. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic response. Am J Physiol Renal Fluid Electrolyte Physiol 258: F781-F789, 1990[Abstract/Free Full Text].

35.   Zou, AP, Drummond HA, and Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 27: 631-635, 1996[Abstract/Free Full Text].

36.   Zou, AP, Imig JD, De Montellano PRO, Sui Z, Falck JR, and Roman RJ. Effect of P-450 omega -hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 266: F934-F941, 1994[Abstract/Free Full Text].

37.   Zou, AP, Imig JD, Kaldunski M, De Montellano PRO, Sui Z, and Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol Renal Fluid Electrolyte Physiol 266: F275-F282, 1994[Abstract/Free Full Text].

38.   Zou, AP, Ma YH, Sui ZH, De Montellano PRO, Clark JE, Masters BS, and Roman RJ. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid w-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268: 474-481, 1994[Abstract].


Am J Physiol Renal Fluid Electrolyte Physiol 278(6):F949-F953
0363-6127/00 $5.00 Copyright © 2000 the American Physiological Society